Related references
Note: Only part of the references are listed.HIV Transmembrane Glycoprotein Conserved Domains and Genetic Markers Across HIV-1 and HIV-2 Variants
Ana Valades-Alcaraz et al.
FRONTIERS IN MICROBIOLOGY (2022)
A targeted covalent small molecule inhibitor of HIV-1 fusion
Guangyan Zhou et al.
CHEMICAL COMMUNICATIONS (2021)
Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV Inhibitors
Samuel Jurado et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Covalent Inhibitors of Protein-Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
Luca Gambini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Lysine-Targeted Inhibitors and Chemoproteomic Probes
Adolfo Cuesta et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88 (2019)
N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein
Jiayin Qiu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Characterization of resistance to a potent d-peptide HIV entry inhibitor
Amanda R. Smith et al.
RETROVIROLOGY (2019)
Investigation of the molecular characteristics of bisindole inhibitors as HIV-1 glycoprotein-41 fusion inhibitors
Guangyan Zhou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Global profiling of lysine reactivity and ligandability in the human proteome
Stephan M. Hacker et al.
NATURE CHEMISTRY (2017)
Lysine-Targeting Covalent Inhibitors
Jonathan Pettinger et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41
Lu Lu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Targeted Covalent Inhibitors for Drug Design
Thomas A. Baillie
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Mechanism of HIV-1 Resistance to Short-Peptide Fusion Inhibitors Targeting the Gp41 Pocket
Yang Su et al.
JOURNAL OF VIROLOGY (2015)
Design and characterization of swapped-domain constructs of HIV-1 glycoprotein-41 as receptors for drug discovery
Joseph D. Walsh et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2015)
Development of HIV-1 Fusion Inhibitors Targeting gp41
K. Lu et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Structure-Activity Relationship Studies of Indole-Based Compounds as Small Molecule HIV-1 Fusion Inhibitors Targeting Glycoprotein 41
Guangyan Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
HIV entry: a game of hide-and-fuse?
Gregory B. Melikyan
CURRENT OPINION IN VIROLOGY (2014)
Small molecule fusion inhibitors: Design, synthesis and biological evaluation of (Z)-3-(5-(3-benzyl-4-oxo-2-thioxothiazolidinylidene)methyl)-N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrroles and related derivatives targeting HIV-1 gp41
Xiao-Yang He et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Identification of fragments targeting an alternative pocket on HIV-1 gp41 by NMR screening and similarity searching
Shidong Chu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
A Suite of Modular Fluorescence Assays Interrogate the Human Immunodeficiency Virus Glycoprotein-41 Coiled Coil and Assist in Determining Binding Mechanism of Low Molecular Weight Fusion Inhibitors
Miriam Gochin
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2012)
Discovery of Critical Residues for Viral Entry and Inhibition through Structural Insight of HIV-1 Fusion Inhibitor CP621-652
Huihui Chong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Development of Indole Compounds as Small Molecule Fusion Inhibitors Targeting HIV-1 Glycoprotein-41
Guangyan Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Design, Synthesis, and Biological Activity of Novel 5-((Arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 Fusion Inhibitors Targeting gp41
Shibo Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A Data Processing Pipeline for Mammalian Proteome Dynamics Studies Using Stable Isotope Metabolic Labeling
Shenheng Guan et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
A time-of-drug addition approach to target identification of antiviral compounds
Dirk Daelemans et al.
NATURE PROTOCOLS (2011)
Design of a Potent D-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance
Brett D. Welch et al.
JOURNAL OF VIROLOGY (2010)
Endocytosis of HIV: anything goes
Marc Permanyer et al.
TRENDS IN MICROBIOLOGY (2010)
Early Steps of HIV-1 Fusion Define the Sensitivity to Inhibitory Peptides That Block 6-Helix Bundle Formation
Kosuke Miyauchi et al.
PLOS PATHOGENS (2009)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1
Lifeng Cai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Binding of antifusion peptides with HIVgp41 from molecular dynamics simulations: Quantitative correlation with experiment
Bentley Strockbine et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion
GB Melikyan et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
